OFM

Omega Fund Management Portfolio holdings

AUM $154M
This Quarter Return
+27.15%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$312M
AUM Growth
+$312M
Cap. Flow
+$135M
Cap. Flow %
43.2%
Top 10 Hldgs %
97.81%
Holding
15
New
1
Increased
–
Reduced
–
Closed
2

Top Buys

1
GOSS icon
Gossamer Bio
GOSS
$151M

Top Sells

1
KZR icon
Kezar Life Sciences
KZR
$15.9M
2
EGLT
Egalet Corporation
EGLT
$7K

Sector Composition

1 Healthcare 99.21%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
GOSS icon
1
Gossamer Bio
GOSS
$562M
$151M 48.31% +6,953,416 New +$151M
REPL icon
2
Replimune Group
REPL
$422M
$77.4M 24.82% 5,103,455 – –
TBIO
3
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$24.8M 7.96% 2,437,603 – –
PRTK
4
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$13.9M 4.47% 2,600,410 – –
OBSV
5
DELISTED
ObsEva SA Ordinary Shares
OBSV
$12.8M 4.1% 999,364 – –
CBAY
6
DELISTED
Cymabay Therapeutics
CBAY
$7.32M 2.35% 551,477 – –
FGEN icon
7
FibroGen
FGEN
$47.8M
$7.1M 2.28% 130,646 – –
CDTX icon
8
Cidara Therapeutics
CDTX
$1.66B
$4M 1.28% 1,508,794 – –
EPIX icon
9
ESSA Pharma
EPIX
$11.4M
$3.7M 1.19% 1,084,848 – –
JNCE
10
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$3.29M 1.05% 529,965 – –
PVLA
11
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
$2.61M 0.84% 778,230 – –
DRNA
12
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$2.45M 0.79% 167,157 – –
SNNA
13
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$1.76M 0.56% 758,610 – –
KZR icon
14
Kezar Life Sciences
KZR
$28.9M
– – -675,623 Closed -$15.9M
EGLT
15
DELISTED
Egalet Corporation
EGLT
– – -2,889,926 Closed -$7K